研究发现,患有与RSV相关的呼吸道感染的成人的一年死亡风险高2.7倍。 Adults with RSV-linked respiratory infections have a 2.7 times higher one-year death risk, study finds.

最近在ESCMID Global 2025进行的一项研究发现,患有呼吸道同步病毒(RSV)相关急性呼吸道感染的成年人在一年内的死亡风险比一般人口高出2.7倍。 A recent study at ESCMID Global 2025 found that adults with respiratory syncytial virus (RSV)-associated acute respiratory infections face a 2.7 times higher risk of death within one year compared to the general population. 这项研究分析了2011年至2022年期间5 289名有RSV-ARI的成人,发现他们的住院率较高,青蒿素综合症和哮喘更经常恶化,伊斯兰法院联盟的入院率更高。 The study analyzed 5,289 adults with RSV-ARI from 2011 to 2022 and found they had higher hospitalization rates, more frequent exacerbations of COPD and asthma, and higher ICU admissions. 这些患者的直接保健费用是没有RSV-ARI的两倍以上。 Direct healthcare costs for these patients were more than double those without RSV-ARI. 研究人员建议优先为脆弱群体接种疫苗,以减少健康并发症和费用。 Researchers recommend prioritizing vaccination for vulnerable groups to reduce health complications and costs.